Search

Scientists in the two newest EU members may have more reason to cheer their accession than the farmers and labourers who were expected to benefit most.

A new report from the OECD makes uncomfortable reading for anyone in Switzerland involved in educational R&D.

Who cares about Brussels? Apparently scientists do, with over 200,000 application forms for its €4 billion fund already downloaded. What next? Commissioner Janez Potočnik wants an EU-wide debate.

Under pressure to demonstrate economic returns on research spending, the UK’s research councils are going to make academics think commercial and to cosy up to industry.

The Lisbon strategy aim of making Europe the leading knowledge-based economy remains a far-off aspiration. Now the UK wants a fresh approach to the single market to move things forward.

In the lean years since the post-genomics bust, venture funding has been hard to come by for Europe’s biotech start-ups. Now they have polished up their business models, and valuations are low, attracting investors back in.

Europe’s companies increasingly recognise that they need to switch from fierce protection to licensing widely to generate revenues.

The French presidential election is unlike any previous one: this time, both right and left are hoisting research policy to the top of their agendas.

As the German presidency gets into its stride, Framework Programme 7 was officially launched last week, with a two day event in Bonn.

The Czech Republic has capped off a series of investments by US software companies with the news that Red Hat is to set up a development centre in Brno.

A shortage of later stage projects is forcing companies hunt further down the drug discovery ladder. Now the Wellcome Trust is injecting charitable money to fill the holes.

Science is an international affair, of course. But a few recent news tidbits highlight just how fast that international dimension is expanding.

The company may top the US's patents league, but IBM still thinks the system is broken.